Pediatric Vaccine Market Expected to Reach $36.4 Billion by 2031

Pediatric vaccines are administered to a child in their pediatric age, which is from 0-18 years. Vaccines are generally given to prevent children from diseases transferred through infections, seasonal variations and even through unhygienic areas. Depending upon disease, vaccines are administered at regular intervals. WHO has designed a standard immunization program to have desired time interval between vaccines doses.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
Serum Institute of India Pvt. Ltd., Emergent BioSolutions Inc., AstraZeneca Plc., GlaxoSmithKline Plc., Johnson & Johnson, Sanofi Aventis, Novavax, Inc., CSL Limited, Pfizer Inc., Merck & Co., Inc.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/438

Key factors that drive the growth of the pediatric vaccine market size is increasing awareness regarding benefits of vaccination in prevention of diseases, rising economic growth, the collaboration of national manufacturers with key players in view to provide high-quality vaccines in at remote areas and initiative by global key players in developing innovative vaccines. Moreover, favorable reimbursement and increasing government support is further expected to boost the market growth during forecast period. However, rising cost of vaccines, low accessibility to remote areas and increasing the availability of biosimilars at low rates is likely to hamper the growth of the pediatric vaccine market during the forecast period. Conversely, rise in demand in emerging markets, increase in R&D activities to develop new vaccines in the pediatric vaccine industry, and surge in healthcare spending are expected to provide numerous opportunities for market growth during the pediatric vaccine market forecast.

By type, the monovalent segment has largest contribution in pediatric vaccine market share in 2021, and is expected to remain dominant during the forecast period, owing to safety and stability associated with such vaccines coupled with the ability to develop a prompt immune response. In addition, increase in awareness regarding vaccination program, improvement in diagnostic procedures, improving health care services in pediatric vaccines industry, rapid economic growth in developing countries and rise in research and development activities to develop vaccine further boost the pediatric vaccine market trends.

Depending on technology, the subunit, recombinant, polysaccharide, and conjugate vaccines segment has largest contribution in pediatric vaccine market share in 2021, and is expected to remain dominant during the forecast period, owing to these vaccines are considered to be the most efficient alternative to traditional vaccines in the prevention of various human diseases. In addition, the increase in number of regulatory clearances have made the highest impact on the market in recent years.

By indication, the pneumococcal segment dominated the market in 2021, and is expected to remain dominant during the forecast period, owing to introduction of novel pneumococcal vaccines in the market, initiatives taken by governments such various immunization programs for pneumonia, and rise in awareness among patients regarding pneumococcal vaccines.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/438

𝐕𝐀𝐋𝐔𝐄 𝐏𝐑𝐎𝐏𝐎𝐒𝐈𝐓𝐈𝐎𝐍𝐒 𝐑𝐄𝐋𝐀𝐓𝐄𝐃 𝐓𝐎 𝐓𝐇𝐄 𝐑𝐄𝐏𝐎𝐑𝐓:

Powered with Complimentary Analyst Hours and Expert Interviews with Each Report

Comprehensive quantitative and qualitative insights at segment and sub-segment level

Covid 19 impact trends and perspective

Granular insights at global/regional/country level

Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Blanket coverage on competitive landscape

Winning imperatives

Exhaustive coverage on 'Strategic Developments' registered by leading players of the market

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.